Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/21341675

J. Med. Chem. 2011 Mar 24 54 6 1871-95

Download in:

View as

General Info

PMID
21341675